Nimbus, Bristol-Myers Can't Sell Psoriasis Drug Amid Dispute
A New York federal court is blocking the sale of a psoriasis treatment under development by Nimbus Therapeutics LLC until after a dispute plays out with Bristol-Myers Squibb Co. over purchase...To view the full article, register now.
Already a subscriber? Click here to view full article